Clinical Trial Update: Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension [Phase 4]

View source ↗

Summary

This update notes the completion of a Phase 4 trial comparing valsartan plus amlodipine versus amlodipine alone for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• DIOVAN (valsartan)
• NORVASC (amlodipine besylate)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED